Local preview using the live theme CSS. Header and footer omitted. Yellow = placeholder to replace.
IRCE > Grants > SECURE-Nigeria

SECURE-Nigeria

← Back to Grants
Completed Global Health Security Disease Surveillance Funded by US CDC

Strengthening Global Health Security Agenda in Nigeria (SECURE-Nigeria)

A five-year national health security programme that strengthened how Nigeria detects, reports, analyses and responds to outbreaks of epidemic-prone diseases.

Implemented by the Institute of Human Virology Nigeria (IHVN) with funding and technical assistance from the United States Centers for Disease Control and Prevention (US CDC), SECURE-Nigeria closed gaps found by Nigeria’s 2017 Joint External Evaluation of the International Health Regulations (IHR 2005): in disease surveillance, use of data, laboratory capacity and workforce skills.

Working with the Nigeria Centre for Disease Control and Prevention (NCDC), the National Primary Health Care Development Agency and State Ministries of Health, it built national digital systems that NCDC now owns and runs. From 2021, additional funding supported Nigeria’s COVID-19 response.

16Disease-specific case forms built into SORMAS, the national reporting system
21,389Reports of health problems after COVID‑19 vaccination reviewed
30Clinics with infection prevention and control teams
11Priority diseases now confirmed by molecular (PCR) testing
60,000+Samples tested for antibodies to COVID‑19
6Sentinel hospitals testing patients with sudden fever

From gaps to goals

What the 2017 Joint External Evaluation found

  • Laboratory results travelled separately from disease reports, so confirmation reached decision-makers late.
  • No electronic reporting system could share data with other national systems, such as DHIS2.
  • Frontline health workers had little capacity to check the quality of the data they reported.
  • Skills to analyse surveillance data were concentrated at national level and scarce in the states.

What SECURE-Nigeria set out to do

  1. Develop surveillance tools that bring data together and present it for analysis at NCDC and State Ministries of Health
  2. Introduce performance management to improve the flow and quality of surveillance data reported into SORMAS, the national disease reporting system
  3. Improve the national surveillance information system, and build a Public Health Informatics workforce at NCDC able to maintain it
  4. Provide training and resources that improve surveillance and outbreak response
  5. Strengthen national and state laboratories to diagnose priority diseases using molecular tests

See how each objective was delivered in the programme map.

Next: Sub-projects →

Sub-projects

SECURE-Nigeria was delivered through seven sub-projects. Select one to read about it in detail.

Programme map

1. How the sub-projects work together

Each sub-project strengthens one link in the chain from spotting a possible outbreak to acting on it.

  1. Detect

    Find possible outbreaks early and confirm them in the laboratory.

  2. Report

    Record every case in the national reporting system.

  3. Check

    Review data quality every month and fix the gaps.

  4. Analyse

    Turn the data into reports, alerts and dashboards.

  5. Act

    NCDC and state emergency operations centres respond, and record what they did.

    NCDC and state EOCs
Protect

Alongside the chain: keep health workers, patients and vaccine recipients safe.

2. From objective to outcome

Every sub-project, what it set out to do, what it delivered and what changed as a result.

Core programme

ObjectiveImprove the national surveillance information system and build a workforce at NCDC able to maintain it.
What was delivered
  • Platform upgraded across 19 versions
  • 16 disease-specific case forms
  • Faster download manager and automatic data checks
  • 13 NCDC officers trained; governance framework adopted
OutcomeA modern national reporting system that NCDC can run and improve itself.
ObjectiveUse performance management to improve the flow and quality of data reported into SORMAS.
What was delivered
  • Data quality teams at NCDC and in states
  • Monthly review meetings
  • Four data quality measures
  • Pilot in four states
OutcomeBetter, more complete surveillance data for decisions.
ObjectiveBuild tools that bring surveillance data together for analysis at NCDC and in states.
What was delivered
  • 10 analysis modules
  • Automatic Weekly Epidemiological Report
  • Threshold alerts and decision tracker
  • Six state emergency operations centres, then all 37 from January 2024
OutcomeFaster, evidence-based outbreak response, owned by NCDC.
ObjectiveStrengthen national and state laboratories to diagnose priority diseases with molecular tests.
What was delivered
  • PCR testing for 11 diseases in 7 laboratories
  • Quality assurance programmes
  • 60,224 samples tested for COVID-19 antibodies
  • Back-up biorepository and Lassa fever laboratory in Akure
OutcomeOutbreaks confirmed sooner, closer to patients.
Sub-projectWorkforce development Across all sub-projects
ObjectiveProvide training and resources that improve surveillance and outbreak response.
What was delivered
  • Epidemiology and data analysis training (Stata and R)
  • E-learning videos
  • NCDC outbreak data analysis team
  • SOPs, user guides and toolkits
OutcomeSkilled staff at NCDC and in states to analyse and act on data.

COVID-19 response

ObjectiveGive early warning of outbreaks by testing patients with sudden fever.
What was delivered
  • 6 sentinel hospitals
  • Laboratory confirmation for 9 diseases
  • More than 11,000 samples tested
OutcomeEarly detection of Mpox (2022) and warning of dengue fever (2025).
ObjectiveMonitor the safety of COVID-19 vaccines.
What was delivered
  • 21,389 reports recorded and reviewed
  • Dashboard linking DHIS2 and MedSafety
  • Evaluation of the national reporting system
OutcomeA complete national picture of COVID-19 vaccine safety.
ObjectiveStop infections spreading inside health facilities.
What was delivered
  • 30 clinics with IPC teams
  • 237,221 patients screened on arrival
  • Three yearly WHO assessments
  • Hand hygiene programme
OutcomeSafer facilities for patients and staff.

Two funding tracks

Core programme (2020 to 2025)

Surveillance systems, use of data, laboratories and workforce skills, addressing the gaps found in the 2017 Joint External Evaluation.

COVID-19 response (from 2021)

Additional funding under the United States CARES Act for early warning of outbreaks, COVID-19 vaccine safety monitoring and infection control in health facilities.

Next: Results →

Results

Key achievements

SORMASSORMAS Optimisation

A modernised national disease reporting system

Nigeria’s Surveillance Outbreak Response Management and Analysis System (SORMAS) was upgraded to the current global version, closing a gap of 19 versions. It now has 16 disease-specific forms, automatic data checks and much faster data downloads.

DAVTData Analytics and Visualisation Tool

Automated outbreak intelligence

The Data Analytics and Visualisation Tool (DAVT) now produces NCDC’s Weekly Epidemiological Report automatically, raises alerts when case numbers pass set thresholds, records what action was taken, and compares data from several reporting systems. It was first deployed in six states and, from January 2024, in all 36 states and the Federal Capital Territory.

SDQMSurveillance Data Quality Management

Routine checks on data quality

Surveillance Data Quality Management (SDQM) teams at NCDC and in states now meet every month to review the quality of surveillance data and act on the gaps they find.

AFIAcute Febrile Illness Sentinel Surveillance

Earlier warning of outbreaks

Six hospitals now test patients with sudden fever for nine diseases. This contributed to the early detection of Mpox in 2022 and warned of rising dengue fever in 2025.

AEFICOVID-19 Vaccine Safety Surveillance

Safer COVID-19 vaccination

21,389 reports of side effects or health problems after COVID-19 vaccination were recorded across five states. Fewer than 1 in 100 were serious. A dashboard brought together reports held in separate government systems.

SORMASSORMAS Optimisation

A skilled team inside NCDC

Thirteen NCDC Public Health Informatics officers were trained to maintain and improve SORMAS, supported by standard operating procedures, user guides, videos and formal rules for managing changes.

The project also trained surveillance officers in epidemiology and data analysis using Stata and outbreak reporting using R, produced e-learning videos, and helped NCDC set up a Coordinated Outbreak Data Analysis Core team to analyse outbreaks and disease trends. It set up a biorepository (a secure store for biological samples) at the Central Public Health Laboratory in Yaba, Lagos, as a back-up to the National Reference Laboratory in Abuja, and supported genetic sequencing of the virus that causes COVID-19.

Next: Where we worked →

Where SECURE-Nigeria worked

SORMAS and DAVT serve the whole country. Seven states received direct support from IHVN, and specific activities took place in several others.

Map of Nigeria showing the states where SECURE-Nigeria worked AbiaAdamawaAkwa IbomAnambraBauchi: Sentinel hospital for fever surveillance; DAVT in the state emergency operations centreBayelsaBenueBornoCross RiverDeltaEbonyi: Data quality pilotEdo: Sentinel hospital in Benin City; detected the 2025 dengue outbreak; DAVT in the state emergency operations centreEkitiEnugu: Sentinel hospital for fever surveillance; DAVT in the state emergency operations centreFederal Capital Territory: National Reference Laboratory, Gaduwa; Sentinel hospital for fever surveillance; HIV clinics with infection control teams; Data quality pilotGombeImoJigawaKaduna: Sentinel hospital for fever surveillance; DAVT in the state emergency operations centreKanoKatsinaKebbiKogiKwaraLagos: Sentinel hospital for fever surveillance; DAVT in the state emergency operations centre; Back-up biorepository, Central Public Health Laboratory, YabaNasarawa: HIV clinics with infection control teamsNigerOgunOndo: DAVT in the state emergency operations centre; Lassa fever testing at the Infectious Disease Hospital, Akure; Data quality pilotOsunOyo: COVID-19 vaccine safety surveillance; Health worker samples tested for COVID-19 antibodiesPlateau: Health worker samples tested for COVID-19 antibodiesRivers: Health worker samples tested for COVID-19 antibodiesSokoto: Data quality pilotTarabaYobeZamfaraFCTBauchiEdoEnuguKadunaLagosOndoNasarawaOyoSokotoEbonyiRiversPlateau
IHVN-supported state Specific project activity Covered by national systems (SORMAS and DAVT) State boundaries: geoBoundaries (CC BY 4.0)

IHVN-supported states

  • Federal Capital Territory
    • Laboratory National Reference Laboratory, Gaduwa
    • AFI Sentinel hospital for fever surveillance
    • IPC HIV clinics with infection control teams
    • SDQM Data quality pilot
  • Bauchi
    • AFI Sentinel hospital for fever surveillance
    • DAVT DAVT in the state emergency operations centre
  • Edo
    • AFI Sentinel hospital in Benin City; detected the 2025 dengue outbreak
    • DAVT DAVT in the state emergency operations centre
  • Enugu
    • AFI Sentinel hospital for fever surveillance
    • DAVT DAVT in the state emergency operations centre
  • Kaduna
    • AFI Sentinel hospital for fever surveillance
    • DAVT DAVT in the state emergency operations centre
  • Lagos
    • AFI Sentinel hospital for fever surveillance
    • DAVT DAVT in the state emergency operations centre
    • Laboratory Back-up biorepository, Central Public Health Laboratory, Yaba
  • Ondo
    • DAVT DAVT in the state emergency operations centre
    • Laboratory Lassa fever testing at the Infectious Disease Hospital, Akure
    • SDQM Data quality pilot

Other states with project activities

  • Nasarawa
    • IPC HIV clinics with infection control teams
  • Oyo
    • AEFI COVID-19 vaccine safety surveillance
    • Laboratory Health worker samples tested for COVID-19 antibodies
  • Sokoto
    • SDQM Data quality pilot
  • Ebonyi
    • SDQM Data quality pilot
  • Rivers
    • Laboratory Health worker samples tested for COVID-19 antibodies
  • Plateau
    • Laboratory Health worker samples tested for COVID-19 antibodies

Next: Infection prevention and control →

Infection prevention and control

Screening and hand hygiene results from the 30 supported HIV clinics, from the IPC technical brief. Hover over or select any part of a chart for its value; each chart also has a data table.

IPCInfection Prevention and Control

Finding infections at the clinic door

237,221 patients screened on arrival at HIV clinics in the Federal Capital Territory and Nasarawa, November 2021 to September 2023

Tuberculosis

Had symptoms 11,241
Sent for evaluation 11,107
Referred 10,300
Tested 7,998
Confirmed 1,023

1,023 confirmed: 9.1% of patients with symptoms.

COVID-19

Had symptoms 4,764
Sent for evaluation 4,641
Referred 3,124
Tested 1,867
Confirmed 120

120 confirmed: 2.5% of patients with symptoms.

Show data table
StepTuberculosisCOVID-19
Had symptoms11,2414,764
Sent for evaluation11,1074,641
Referred10,3003,124
Tested7,9981,867
Confirmed1,023120

Source: IPC technical brief

IPCInfection Prevention and Control

Hand hygiene compliance by staff group

Share of observed hand hygiene opportunities where staff complied, over 16 months

Doctors
Nurses
Other staff
Laboratory scientists
Show data table
Staff groupCompliance
Doctors65%
Nurses58%
Other staff54%
Laboratory scientists52%

Source: IPC technical brief

IPCInfection Prevention and Control

Hand hygiene compliance by service point

Share of observed opportunities complied with, over 16 months

0%25%50%75%100%
64%
Consulting rooms
64%
Paediatric HIV clinic
58%
Nursing station
58%
Obstetrics and gynaecology
54%
Tuberculosis treatment
44%
Specimen collection
Show data table
Service pointCompliance
Consulting rooms64%
Paediatric HIV clinic64%
Nursing station58%
Obstetrics and gynaecology58%
Tuberculosis treatment54%
Specimen collection44%

Source: IPC technical brief

Next: Data quality →

Data quality

Results from the data quality pilot, from the SECURE-Nigeria dissemination report. Hover over or select any part of a chart for its value; each chart also has a data table.

SDQMSurveillance Data Quality Management

How completely SORMAS captured cases

Cases in SORMAS as a share of cases on state line lists, data quality pilot in Ondo, Sokoto, Ebonyi and the FCT, October 2023 to September 2024

  • 90% and above
  • 80 to 89%
  • Below 80%
  • All line-list cases in SORMAS (100%)
Lassa fever 105%
Diphtheria 96%
Cholera 93%
Cerebrospinal meningitis 93%
Measles 90%
Mpox 90%
COVID-19 84%
Yellow fever 81%
Dengue fever 75%
Acute flaccid paralysis 74%

Above 100% means SORMAS held more cases than the paper line list. Lower scores pointed teams to the diseases needing follow-up.

Show data table
DiseaseCases in SORMAS as a share of the line list
Lassa fever105%
Diphtheria96%
Cholera93%
Cerebrospinal meningitis93%
Measles90%
Mpox90%
COVID-1984%
Yellow fever81%
Dengue fever75%
Acute flaccid paralysis74%

Source: SECURE-Nigeria dissemination report

Next: Laboratory →

Laboratory

Serological surveillance results from the National Reference Laboratory. Hover over or select any part of a chart for its value; each chart also has a data table.

LaboratoryLaboratory Optimisation

Samples tested for COVID-19 antibodies

Tested at the National Reference Laboratory using multiplex bead assay

Leftover HIV viral load samples, six geopolitical zones: 42,820 (71.1%)Antenatal dried blood spots, four states: 15,252 (25.3%)Health workers in Rivers, Oyo and Plateau: 2,152 (3.6%) 60,224 samples
  • Leftover HIV viral load samples, six geopolitical zones42,82071.1%
  • Antenatal dried blood spots, four states15,25225.3%
  • Health workers in Rivers, Oyo and Plateau2,1523.6%
Show data table
Sample groupSamplesShare
Leftover HIV viral load samples, six geopolitical zones42,82071.1%
Antenatal dried blood spots, four states15,25225.3%
Health workers in Rivers, Oyo and Plateau2,1523.6%

Source: SECURE-Nigeria dissemination report

Next: SORMAS optimisation →

SORMAS optimisation

Training and performance results from the optimisation of SORMAS. Hover over or select any part of a chart for its value; each chart also has a data table.

SORMASSORMAS Optimisation

SORMAS training: knowledge gained

Average assessment score of NCDC Public Health Informatics officers

  • Score before training
  • Gain after training
63.3% +18.4 81.7%
0%50%100%

An 18.4 percentage point gain, from 63.3% to 81.7%.

Show data table
MeasureScore
Before training63.3%
After training81.7%
Gain+18.4 points

Source: SORMAS workforce development records

SORMASSORMAS Optimisation

SORMAS training: workshop projects completed

Each square is one participant

  • Fully completed
  • Not fully completed
Java console application (July) 8 of 8
SORMAS sign-in page prototype (July) 6 of 8
Java web application with database (August) 15 of 15
Relational database design (August) 15 of 15
Show data table
ProjectCompletedParticipants
Java console application (July)88
SORMAS sign-in page prototype (July)68
Java web application with database (August)1515
Relational database design (August)1515

Source: SORMAS workforce development manuscript (in preparation)

SORMASSORMAS Optimisation

SORMAS: time to download a large dataset

Minutes to download more than 500 records, before and after the optimisation

  • Before: more than 15 minutes, often failed
  • After: under 3 minutes
15+ min Under 3 min
016 min
Show data table
MeasureBefore: more than 15 minutes, often failedAfter: under 3 minutes
Download time15+ minUnder 3 min

Source: SORMAS optimisation technical narrative

Next: Milestones →

Milestones

Programme Core programme COVID-19 response Follow-up or continuing work 1Key milestone
2020202120222023202420252026
Programme

Select a numbered marker to jump to that milestone. On a phone, swipe the chart sideways.

2020

  1. 1
    September 2020 Programme begins

    The SECURE-Nigeria cooperative agreement between US CDC and IHVN starts.

    Programme

2021

  1. 2
    2021 COVID-19 funding added

    Additional funding under the United States CARES Act extends the project to Nigeria’s COVID-19 response.

    Programme
  2. 3
    April 2021 Vaccine safety reports brought together

    Work begins to combine reports of health problems after COVID-19 vaccination from separate national systems.

    AEFI
  3. 4
    2021 Fever surveillance begins

    Sentinel hospitals start testing patients with sudden fever for nine diseases.

    AFI
  4. 5
    November 2021 Every patient screened on arrival

    Supported clinics start screening all patients for COVID-19 and tuberculosis.

    IPC

2022

  1. 6
    2022 Mpox detected early

    Fever surveillance contributes to the early detection of Mpox in Nigeria.

    AFI
  2. 7
    July 2022 Vaccine safety dashboard in use

    The dashboard goes to the national COVID-19 vaccination technical working group.

    AEFI
  3. 8
    September 2022 DAVT launched

    Launched at NCDC by the then Director General, Dr Ifedayo Adetifa.

    DAVT

2023

  1. 9
    October 2023 Data quality pilot begins

    Monthly data quality reviews start in Ondo, Sokoto, Ebonyi and the Federal Capital Territory.

    SDQM
  2. 10
    October 2023 Hand hygiene programme

    A 12-month hand hygiene programme starts in the supported clinics.

    IPC

2024

  1. 11
    January 2024 DAVT goes nationwide

    DAVT is expanded from six states to all 36 states and the Federal Capital Territory.

    DAVT
  2. 12
    September 2024 SORMAS user toolkit finalised

    A data entry guide for SORMAS users, shaped by the data quality findings.

    SDQM

2025

  1. 13
    March 2025 Lassa fever testing in Akure

    The Infectious Disease Hospital in Ondo State starts confirming Lassa fever on site.

    Laboratory
  2. 14
    March 2025 SORMAS optimisation begins

    Assessment and redesign of the national disease reporting system starts.

    SORMAS
  3. 15
    April 2025 SORMAS upgraded

    Nigeria’s SORMAS moves to version 1.101.0, closing a 19-version gap.

    SORMAS
  4. 16
    May 2025 Vaccine safety evaluation shared

    Findings presented to NPHCDA, NAFDAC and partners in Abuja.

    AEFI
  5. 17
    2025 Dengue fever warning

    Fever surveillance flags rising dengue, including an outbreak of 194 confirmed cases in Edo State.

    AFI
  6. 18
    July 2025 Validation and training workshops

    Users test the new system; NCDC officers attend the first of two five-day workshops.

    SORMAS
  7. 19
    August 2025 DAVT optimised

    Automatic weekly report, line-list upload and data quality tools go live.

    DAVT
  8. 20
    September 2025 Cooperative agreement ends

    The five-year award period closes.

    Programme
  9. 21
    November 2025 Results shared

    Dissemination and close-out meeting with government and partners in Abuja.

    Programme
  10. 22
    December 2025 Handover to NCDC agreed

    Transfer of SORMAS and DAVT to NCDC agreed with the NCDC Director General.

    Programme

2026

  1. 23
    January to February 2026 Final acceptance testing

    Structured testing of the optimised SORMAS by national users before go-live.

    SORMAS

Next: Team →

Project team

The people who led and delivered SECURE-Nigeria at IHVN. Select “Read full profile” to see each person’s contribution, expertise and background.

Photo of Prof. Alash’le Abimiku

Prof. Alash’le Abimiku, MSc, PhD, MON

Principal Investigator, SECURE-Nigeria; Executive Director, International Research Center of Excellence (IRCE), IHVN

A co-founder of the Institute of Human Virology Nigeria (IHVN) and Professor in the Department of Medicine at the University of Maryland School of Medicine. For more than 30 years she has led efforts to build quality laboratory medicine and research in Nigeria and across Africa.

Read full profileHide full profile

Contribution to SECURE-Nigeria

  • Principal Investigator of SECURE-Nigeria, providing scientific leadership and strategic direction across all seven sub-projects from 2020 to 2025.
  • Led IHVN’s partnership with the Nigeria Centre for Disease Control and Prevention (NCDC), the National Primary Health Care Development Agency, State Ministries of Health and the United States Centers for Disease Control and Prevention.
  • Led engagement with NCDC leadership on the handover of SORMAS and DAVT to national ownership.
  • Co-author of the BMJ Global Health paper on COVID-19 vaccine safety data triangulation in Nigeria.

Areas of expertise

  • Laboratory system strengthening
  • Global health security
  • Surveillance and health systems strengthening
  • Virology and molecular biology
  • Immunology and biospecimen science
  • Infection prevention and control
  • Human capacity building

Experience

  • Executive Director, Laboratory Diagnostics and Research, IHVN
  • Principal Investigator, IHVN H3Africa Biorepository (I-HAB)
  • Chair, Board of Directors, African Society for Laboratory Medicine
  • Member, World Health Organization Scientific Advisory Group for Research and Development Preparedness for Epidemics
  • Member, Coalition for Epidemic Preparedness Innovations (CEPI); member, Africa CDC Africa Laboratory Technical Working Group
  • Fellow of the African Academy of Sciences
  • First to document, in 1993, that the HIV strain most common in Nigeria is subtype G, and established the first reliable HIV research laboratory in central Nigeria

Honours

  • Member of the Order of the Niger (MON), a national honour for contribution to public health and science in Nigeria
  • African Society for Laboratory Medicine Lifetime Achievement Award

Education

  • PhD, Medical Microbiology, London School of Hygiene and Tropical Medicine
  • MSc, Medical Microbiology, London School of Hygiene and Tropical Medicine
  • BSc, Microbiology, Ahmadu Bello University, Zaria
Photo of Rita Okonkwo

Rita Okonkwo, MPH

Project Director, SECURE-Nigeria; Global Health Security, International Research Center of Excellence (IRCE), IHVN

A public health and quality improvement specialist who leads IHVN’s global health security work. Before SECURE-Nigeria she served as a Continuous Quality Improvement Specialist and Senior Continuous Quality Improvement Specialist at IHVN.

Read full profileHide full profile

Contribution to SECURE-Nigeria

  • Directed the day-to-day implementation of SECURE-Nigeria across its seven sub-projects, and led the team that delivered DAVT and the SORMAS optimisation. [confirm]
  • Co-author of the BMJ Global Health paper on COVID-19 vaccine safety data triangulation in Nigeria.
  • Presented the findings of the evaluation of Nigeria’s COVID-19 vaccine safety reporting system to the National Primary Health Care Development Agency, NAFDAC and partners in May 2025.
  • [Add further contributions, for example to infection prevention and control, SDQM and the project close-out]

Areas of expertise

  • Global health security
  • Health system strengthening
  • Quality improvement
  • Implementation science
  • Health policy and research
  • Research administration

Experience

  • Senior Continuous Quality Improvement Specialist, IHVN
  • Continuous Quality Improvement Specialist, IHVN
  • [Add other roles and years]

Education

  • Master of Public Health (MPH) [add institution and year]
Photo of Dr Sophia Oluwakemi Osawe

Dr Sophia Oluwakemi Osawe, PhD, MPH, AIMLS, EMBA

Laboratory Component Lead, SECURE-Nigeria; Senior Research Manager and Head of Research Operations, International Research Center of Excellence (IRCE), IHVN

A laboratory scientist and research manager who heads research operations at IRCE. She led the laboratory component of SECURE-Nigeria and presented the programme’s achievements at its dissemination meeting.

Read full profileHide full profile

Contribution to SECURE-Nigeria

  • Led the laboratory component of SECURE-Nigeria, which expanded molecular (PCR) testing for 11 priority diseases across seven national and state laboratories.
  • Oversaw quality control and external quality assessment programmes, multi-pathogen testing at the National Reference Laboratory, and serological surveillance that tested more than 60,000 samples for antibodies to the virus that causes COVID-19.
  • Oversaw the back-up biorepository at the Central Public Health Laboratory in Lagos and the Lassa fever laboratory at the Infectious Disease Hospital in Akure.
  • Presented SECURE-Nigeria’s achievements to government and partners at the project’s dissemination meeting.

Areas of expertise

  • Laboratory system strengthening
  • Molecular diagnostics
  • Laboratory quality management
  • Biobanking
  • Research operations and management

Experience

  • Head of Research Operations and Senior Research Manager, IRCE, IHVN
  • [Add earlier roles and years]

Education

  • PhD [field and institution: confirm]
  • Master of Public Health (MPH)
  • Executive MBA (EMBA)
  • Associate of the Institute of Medical Laboratory Science (AIMLS)
Photo of Dr Nifarta Peingurta Andrew

Dr Nifarta Peingurta Andrew, PhD, MPH, MSc

Data Lead, International Research Center of Excellence (IRCE), IHVN; Research Manager and Data Unit Lead

A monitoring and evaluation specialist and public health data scientist with more than 12 years’ experience in data management and analysis. She leads data for IRCE, the IHVN centre through which SECURE-Nigeria was implemented.

Read full profileHide full profile

Contribution to SECURE-Nigeria

  • Data lead for IRCE, overseeing data management, quality and analysis standards across the programmes IRCE implements, including SECURE-Nigeria.
  • [Add specific contributions to SECURE-Nigeria]

Areas of expertise

  • Monitoring and evaluation
  • Data management
  • Research and clinical trial databases
  • Statistical modelling
  • Public health data science

Experience

  • Research Manager and Data Unit Lead, IRCE, IHVN
  • Program Manager (Research), IRCE, IHVN
  • Facilitator, IRCE Public Health Data Analysis Training Course

Education

  • PhD, Educational Policy, University of Korinthos, Greece
  • Master of Public Health, Texila American University
  • MSc, Statistics, University of Ibadan
  • BSc, Statistics, University of Maiduguri
Photo of Saiki Adinoyi Musa

Saiki Adinoyi Musa, [Degrees: confirm]

Epidemiology and Surveillance Manager, SECURE-Nigeria, International Research Center of Excellence (IRCE), IHVN

An epidemiologist who manages the surveillance and epidemiology work of SECURE-Nigeria, linking national systems at NCDC with the states, laboratories and health facilities that use them. He is a public advocate for One Health preparedness, the approach that joins up human, animal and environmental surveillance.

Read full profileHide full profile

Contribution to SECURE-Nigeria

  • Managed the epidemiology and surveillance work of SECURE-Nigeria, including the teams that delivered DAVT and the SORMAS optimisation.
  • Led IHVN’s support to the laboratory at the Infectious Disease Hospital in Akure, Ondo State, which in March 2025 began testing for Lassa fever on site. Before this, samples had to travel to the Federal Medical Centre in Owo, delaying results and patient care. Ondo State accounted for 32% of Nigeria’s confirmed Lassa fever cases in 2023.
  • Coordinated with NCDC leadership and State Ministries of Health on project delivery and on the handover of SORMAS and DAVT to NCDC.
  • [Add further contributions, for example to SDQM and acute febrile illness surveillance]

Areas of expertise

  • Disease surveillance and epidemiology
  • Outbreak preparedness and response
  • Laboratory and surveillance linkage
  • One Health surveillance
  • Lassa fever and viral haemorrhagic fevers
  • Stakeholder coordination with NCDC and states

Experience

  • Epidemiology and Surveillance Manager, SECURE-Nigeria, IHVN
  • Commentator on national preparedness for emerging threats such as Ebola and hantavirus, calling for stronger One Health surveillance, health worker training and state-level laboratory and genomic capacity
  • [Add earlier roles and years]

Education

  • [Degrees, institutions and years: confirm]
Photo of Oyewole Oyedele

Oyewole Oyedele, MSc Biostatistics, MSc Statistics

SDQM Lead, SECURE-Nigeria; Biostatistician and Technical Lead, Public Health Informatics, International Research Center of Excellence (IRCE), IHVN

A biostatistician with more than 10 years’ experience, skilled in R, Python and Stata for advanced epidemiological, statistical and machine learning models. He led Surveillance Data Quality Management under SECURE-Nigeria.

Read full profileHide full profile

Contribution to SECURE-Nigeria

  • Led Surveillance Data Quality Management (SDQM): the monthly, team-based review of surveillance data quality at NCDC and in State Ministries of Health.
  • Led the SDQM pilot in Ondo, Sokoto, Ebonyi and the Federal Capital Territory (October 2023 to September 2024), including the four quality measures reviewed every month.
  • Turned SDQM findings into improvements, which shaped the optimisation of SORMAS and the data quality tools in DAVT.

Areas of expertise

  • Biostatistics
  • Surveillance data quality
  • Epidemiological and statistical modelling
  • Machine learning
  • R, Python and Stata
  • Public health informatics

Experience

  • Biostatistician and Technical Lead, Public Health Informatics, IRCE, IHVN
  • Facilitator, IRCE Public Health Data Analysis Training Course
  • Author of peer-reviewed studies on maternal and newborn care in Nigeria

Education

  • MSc, Biostatistics
  • MSc, Statistics
  • [Institutions and years: confirm]
Photo of Ubokobong Effiong

Ubokobong Effiong, M.Sc. Public Health

Health Informatics Expert and Technical Lead, Global Health Security, IHVN

A health informatics and digital disease surveillance specialist with more than seven years’ experience designing, building and scaling health information systems in Nigeria. Under SECURE-Nigeria he was the architect and implementation lead for DAVT and the technical lead for the optimisation of SORMAS, Nigeria’s national disease reporting system.

Read full profileHide full profile

Contribution to SECURE-Nigeria

  • DAVT: Architect and implementation lead. Led six months of co-design workshops with NCDC leadership and technical working groups, WHO Nigeria, State Ministries of Health, US CDC and frontline surveillance officers. Designed the automated Weekly Epidemiological Report, threshold alerts with the decision tracker, maps, multi-source data comparison and role-based dashboards, cutting production of the weekly report from five to six weeks of manual work to near real time.
  • New DAVT modules: Designed and built the digital Weekly Epidemiological Report workflow, automatic situation reports, the National IDSR Compliance Index and the advanced analytics suite.
  • SORMAS optimisation: Technical lead. Benchmarked Nigeria’s SORMAS against the global release (19 versions behind), led the redesign of 18 disease-specific electronic case investigation forms with their validation rules, fixed the failing download manager, and built the line-list upload used when SORMAS is unavailable.
  • User validation: Designed a 23-item assessment used with 25 users across health facility, local government, state and national levels, and used the results to prioritise more than 40 issues for fixing before go-live.
  • Data quality: Implemented Surveillance Data Quality Management alongside DAVT and expanded it to seven states. For yellow fever, the ratio of cases on paper records to cases in SORMAS moved from 1.64 in 2022 to 0.99 in 2025, meaning the two records now almost match.
  • Training and governance: Designed and delivered the Learn, Do, Sustain training programme for NCDC Public Health Informatics officers. Average knowledge scores rose from 63.3% to 81.7%, and all 15 participants in the advanced workshop completed their projects. Co-designed the SORMAS governance framework adopted by NCDC and the skills-based handover plan.

Areas of expertise

  • Digital disease surveillance (SORMAS, DHIS2)
  • Surveillance analytics and dashboards
  • Health information system architecture
  • Interoperability standards (HL7 FHIR)
  • Electronic medical records and laboratory information systems
  • Data quality management
  • Mixed-methods evaluation (Stata, Power BI, SQL)
  • Curriculum design and capacity building
  • Digital health governance
  • IDSR, IHR (2005) and Joint External Evaluation

Experience

  • Health Informatics Expert and Technical Lead, Global Health Security, IHVN (SECURE-Nigeria)
  • Technical and Product Manager, Health in a Box Solutions (2018 to 2025): led a hospital management information system deployed in 25 hospitals, trained more than 4,500 health workers, and was chief architect of the National Health Exchange (NHEX)
  • Scientific Officer and EMR and LIMS Administrator, National Hospital Abuja (2018 to 2023): built the laboratory information system serving the hospital’s four main laboratories and connected laboratory analysers directly to it

Education

  • M.Sc. Public Health, National Open University of Nigeria (2023)
  • B.Sc. Biochemistry, Michael Okpara University of Agriculture, Umudike (2016)

Publications

  • Bridging the data-to-action gap: development and implementation of a national surveillance data analytics and visualisation tool to strengthen epidemic intelligence in Nigeria. Lead co-author. [Status: confirm]
  • Institutionalising competency and governance for sustainable digital surveillance: a community case study of SORMAS optimisation in Nigeria. Lead co-author. [Status: confirm]
  • Evaluating digital surveillance system optimisation through multi-level user validation: a mixed-methods implementation approach. Lead co-author. [Status: confirm]
Photo of Victoria Etuk

Victoria Etuk, [Degrees: confirm]

Surveillance and Epidemiology Specialist, Global Health Security; Project Manager, COVID-19 vaccine safety reporting system evaluation, IHVN

An infectious disease epidemiologist whose work spans global health security, vaccine safety, HIV and tuberculosis. At IHVN she has progressed from data analyst to principal investigator and project lead in surveillance and epidemiology.

Read full profileHide full profile

Contribution to SECURE-Nigeria

  • Managed the evaluation of the DHIS2 system Nigeria used to report health problems after COVID-19 vaccination. Findings were shared with the National Primary Health Care Development Agency, NAFDAC and partners in Abuja in May 2025.
  • Contributed surveillance and epidemiology expertise to SECURE-Nigeria’s global health security work as a project lead.
  • Co-author of a national review of 14,959 reports of health problems after COVID-19 vaccination in Nigeria’s national pharmacovigilance database, which found the four vaccines in use were well tolerated with no safety concerns identified.
  • [Add further contributions]

Areas of expertise

  • Infectious disease epidemiology
  • Vaccine safety surveillance
  • Surveillance system evaluation
  • Data analysis
  • Global health security
  • HIV and tuberculosis research

Experience

  • Surveillance and Epidemiology Specialist and Project Lead, Global Health Security, IHVN
  • Principal Investigator and Data Analyst, IHVN
  • Co-lead, INFORM-Africa pilot project: Vaccine coverage mapping, an important tool for pandemic preparedness (from 2023)
  • Grantee, Global Virus Network Pandemic Preparedness Grant (December 2025), to build a wastewater-based early warning system for emerging pathogens in Nigeria using metagenomics, artificial intelligence and geospatial mapping

Education

  • [Degrees, institutions and years: confirm]

Publications

  • Elemuwa UG, Bitrus F, Abubakar A, Abiodun AS, Faniyi AE, Oreagba IA, Osakwe AI, Onu K, Etuk V, Yuah D, Momodu R, Adeyeye CM. Trends of COVID-19 vaccine adverse event following immunization (AEFI): a one-year retrospective review using the passive surveillance data in the Nigerian national database (VigiFlow). Journal of Population Therapeutics and Clinical Pharmacology. 2024;31(8). doi:10.53555/6vk1cf91
Photo of Edward Aondoakura Kombu

Edward Aondoakura Kombu, [Degrees: confirm]

Senior Data Analyst and Health System Developer, IHVN

A senior data analyst and health system developer with more than 10 years’ experience collecting, validating, storing and analysing public health data for non-governmental organisations. He specialises in building public health databases and dashboards, and in pulling complex data out of platforms such as DHIS2.

Read full profileHide full profile

Contribution to SECURE-Nigeria

  • Infection prevention and control: Key data analyst for the IPC sub-project. Built the IPC dashboards used to track patient screening, facility assessments against World Health Organization standards and hand hygiene compliance across the 30 supported clinics. [confirm and expand]
  • DAVT and SORMAS: A member of the IHVN team that delivered DAVT and the optimisation of SORMAS.
  • Training: Co-facilitated the in-person SORMAS training workshops for NCDC Public Health Informatics officers.

Areas of expertise

  • Public health data analysis
  • Dashboard development (Power BI)
  • Database development
  • DHIS2 data extraction
  • Data governance
  • Machine learning
  • Python, R, SPSS and MATLAB

Experience

  • Senior Data Analyst and Health System Developer, IHVN
  • Developed a stillbirth dashboard in Power BI for Nigeria’s Federal Ministry of Health, now published on the Ministry’s website
  • Implemented data governance practices with partners including the United States Centers for Disease Control and Prevention
  • Facilitator, IRCE Public Health Data Analysis Training Course

Education

  • [Degrees, institutions and years: confirm]

Nathan Ohiomokhare

State Surveillance Officer, Federal Capital Territory, SECURE-Nigeria, IHVN

A pharmacist with a background in pharmacoepidemiology and health supply chains.

Read moreShow less

Contribution to SECURE-Nigeria: Led SECURE-Nigeria’s surveillance work in the Federal Capital Territory, working with the territory’s health services on disease reporting, data quality and outbreak response. [confirm and expand]

Faith Oluwatosin Sangodele, MSc Global Health

State Surveillance Assistant, SECURE-Nigeria, IHVN

A global health professional who previously worked as a Monitoring and Evaluation Officer at the National Primary Health Care Development Agency, supporting the introduction of new vaccines into Nigeria’s routine immunisation programme.

Read moreShow less

Contribution to SECURE-Nigeria: From January 2022, supported COVID-19 vaccine safety surveillance in Oyo State: strengthening active surveillance for health problems after vaccination and working with the state Emergency Operations Centre and WHO to improve reporting across local government areas.

Esosa Osagie, MSc Haematology and Blood Transfusion Science

Laboratory Specialist and Research Officer, IHVN, Benin City

A laboratory scientist who coordinates IHVN research in Benin City, including several studies funded by the United States National Institutes of Health. He is completing a PhD in immunology at the University of Benin.

Read moreShow less

Contribution to SECURE-Nigeria: Coordinated acute febrile illness sentinel surveillance in Edo State, where the sentinel site helped detect the 2025 dengue fever outbreak, and provided laboratory expertise to the programme.

Kazeem Kolawole

Data Analyst, IHVN

[Short profile]

Read moreShow less

Contribution to SECURE-Nigeria: Analysed surveillance and programme data for SECURE-Nigeria. [confirm and expand]

Chijioke Mba

Outbreak Response, IHVN [confirm title]

Works on outbreak investigation and response. Contributed the formal analysis to a 2026 study of Gombe State’s Lassa fever outbreak response, which showed how weak surveillance and data sharing between neighbouring states delays detection.

Read moreShow less

Contribution to SECURE-Nigeria: Supported outbreak response under SECURE-Nigeria. [confirm and expand]

Next: Partners and news →

Funding

Funder United States Centers for Disease Control and Prevention (US CDC) Division of Global Health Protection, with the Global Infectious Disease branch
Cooperative agreement
NU2HGH000020
Period
September 2020 to September 2025
COVID-19 funding
Additional COVID-19 response funding under the United States CARES Act from 2021

Partners

Government of Nigeria

  • Nigeria Centre for Disease Control and Prevention (NCDC)Lead national partner. Owns and runs SORMAS and DAVT.
  • National Primary Health Care Development Agency (NPHCDA)Lead agency for COVID-19 vaccine safety monitoring.
  • National Agency for Food and Drug Administration and Control (NAFDAC)Vaccine safety reporting through the MedSafety app.
  • National Emergency Routine Immunization Coordination CentreCoordination of COVID-19 vaccination.
  • National Expert Committee on Adverse Events Following ImmunisationExpert review of serious health problems after vaccination.

International and technical partners

  • US CDCFunding and technical assistance throughout.
  • World Health Organization, NigeriaHelped develop data quality management and supported vaccine safety work.
  • University of Maryland, BaltimoreBuilt the back end of the vaccine safety dashboard and co-developed DAVT.
  • African Field Epidemiology Network (AFENET)Technical support for vaccine safety surveillance.
  • NIX TechnologyTechnical development partner for the SORMAS optimisation.

Supported states

State Ministries of Health and Public Health Emergency Operations Centres in:

  • Federal Capital Territory
  • Bauchi
  • Edo
  • Enugu
  • Kaduna
  • Lagos
  • Ondo

In the news

Publications and resources

Last updated: September 2026

Contact: Prof. Alash’le Abimiku, Principal Investigator

Enquiries: irceinquiries@ihvnigeria.org

Explore more IRCE research